January 30, 2017
Abilita Bio Signs a New Research Collaboration with a Global Pharmaceutical Company and 2016 Milestone Review
Abilita Bio, Inc. announced today a second research collaboration agreement with a major pharmaceutical partner, which will leverage Abilita Bio’s proprietary EMP™ membrane protein evolution platform to accelerate G protein-coupled receptor (GPCR) drug discovery and development.
September 20, 2016
Abilita Bio, Inc. Awarded NCI Phase-I SBIR Grant to Develop Therapeutic Antibodies Targeting Metastatic Breast Cancer
Abilita Bio, Inc. announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to develop therapeutic antibodies targeting G Protein-Coupled Receptors (GPCRs) involved in the metastasis of breast cancer, including prostaglandin E2 receptor 2 (EP2), prostaglandin E2 receptor 4 (EP4), and C-C chemokine receptor 7 (CCR7).
April 12, 2016
Abilita Bio Appoints Christopher B. Roth, PhD to Vice President, Innovation
Abilita Bio, Inc. announced today that Christopher B. Roth has been appointed to the role of Vice President, Innovation. In conjunction with this appointment, Dr. Roth will step down as a member of Abilita Bio’s Scientific Advisory Board, which he joined in 2015.
December 14, 2015
Primordial Genetics and Abilita Bio Establish Collaboration to Produce Stabilized G Protein-Coupled Receptors (GPCRs) in Bacteria:
Abilita Bio Inc. and Primordial Genetics Inc., a biotechnology company that provides genetic solutions for improvement of production microbes, have signed a collaboration agreement for use of Primordial Genetics’ Function Generator™ genetic improvement technology to develop advanced strains of E. coli for expression of mammalian membrane proteins that have been optimized for structural and drug development efforts using Abilita’s proprietary Enabled Membrane Proteins (EMPs™) technology. To learn more about Primordial Genetics, please see www.primordialgenetics.com
Tracy Handel, PhD: Pharmacology
Professor of Pharmacy, UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences Department of Pharmacology
Wei Liu, PhD: Crystallography
Assistant Professor, Arizona State University Department of Chemistry & Biochemistry and The Biodesign Institute, Applied Structural Discovery
